Vitra Labs is developing a novel in vitro fertilization process that induces oogenesis outside the ovary using proprietary cell culture techniques and bioinformatics for egg maturation. This approach aims to increase accessibility to IVF by reducing costs and simplifying the egg retrieval process for individuals facing infertility.
Funding
$10.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
In vitro fertilization (IVF) relies on egg retrieval, which can be costly, invasive, and have variable efficacy, limiting accessibility for many individuals facing infertility. Current methods often depend on ovarian donor tissue and may not fully address the underlying biological complexities of oogenesis.
Solution
Vitra Labs is developing an in vitro oogenesis process that aims to increase the accessibility and efficacy of IVF. Their approach uses proprietary cell culture techniques and sophisticated bioinformatics tools to induce and support egg maturation outside of the ovary, eliminating the need for donor tissue. By decoupling ovarian signals from ovarian tissue, Vitra Labs seeks to reduce the cost, simplify the process, and improve outcomes associated with traditional egg retrieval methods. The technology leverages high-throughput screening to expedite the discovery of factors needed for egg maturation.
Target Audience
The primary target audience includes individuals and couples experiencing infertility, as well as fertility clinics and assisted reproductive technology (ART) providers seeking to improve IVF outcomes and accessibility.
Features
- Target Identification: Employs bioinformatics tools to identify key signals for egg maturation.
- Cell Engineering: Utilizes proprietary cell culture techniques to deliver maturation factors to cells.
- High-Throughput Screening: Accelerates candidate discovery with real-time readouts.
- In vitro oogenesis process without the use of ovarian donor tissue.